ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with <sup>89</sup> Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol

Publication | Open Access

DOI Full Paper Access

Citations

References

2022

Year

Fiona Hegi‐Johnson, Stacey E. Rudd, Christian Wichmann, Tim Akhurst, Peter Roselt, Jenny Trinh, Thomas John, Lisa Devereux, Paul S. Donnelly, Rodney J. Hicks,

BMJ Open

Abstract

References